Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Yee-Chen Huang

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|March 15, 2018
Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based NanoparticlesMei Zhang, Julian A Kim, Alex Yee-Chen Huang
Frontiers of Medicine|December 17, 2014
Triterpenoid inducers of Nrf2 signaling as potential therapeutic agents in sickle cell disease: a reviewAmma Owusu-Ansah, Sung Hee Choi, Agne Petrosiute, et al.
Plos One|February 22, 2014
Administration of reconstituted polyphenol oil bodies efficiently suppresses dendritic cell inflammatory pathways and acute intestinal inflammationElisabetta Cavalcanti, Elisa Vadrucci, Francesca Romana Delvecchio, et al.
Journal for Immunotherapy of Cancer|August 8, 2023
Functional tumor cell-intrinsic STING, not host STING, drives local and systemic antitumor immunity and therapy efficacy following cryoablationMohammad Alshebremi, Suzanne L Tomchuck, Jay T Myers, et al.
Cancer Communications (London, England)|July 6, 2024
Oral transforming growth factor-beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunitySung Hee Choi, Jay Thomas Myers, Suzanne Louise Tomchuck, et al.
Journal for Immunotherapy of Cancer|June 23, 2025
<i>Piezo1</i> deletion enhances cross-priming of CD8+ T cells by tumor-infiltrating CD11b+ dendritic cellsMelissa Bonner, David Askew, Vrishabhadev Sathish Kumar, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|March 15, 2018
Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based NanoparticlesMei Zhang, Julian A Kim, Alex Yee-Chen Huang
Frontiers of Medicine|December 17, 2014
Triterpenoid inducers of Nrf2 signaling as potential therapeutic agents in sickle cell disease: a reviewAmma Owusu-Ansah, Sung Hee Choi, Agne Petrosiute, et al.
Plos One|February 22, 2014
Administration of reconstituted polyphenol oil bodies efficiently suppresses dendritic cell inflammatory pathways and acute intestinal inflammationElisabetta Cavalcanti, Elisa Vadrucci, Francesca Romana Delvecchio, et al.
Journal for Immunotherapy of Cancer|August 8, 2023
Functional tumor cell-intrinsic STING, not host STING, drives local and systemic antitumor immunity and therapy efficacy following cryoablationMohammad Alshebremi, Suzanne L Tomchuck, Jay T Myers, et al.
Cancer Communications (London, England)|July 6, 2024
Oral transforming growth factor-beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunitySung Hee Choi, Jay Thomas Myers, Suzanne Louise Tomchuck, et al.
Journal for Immunotherapy of Cancer|June 23, 2025
<i>Piezo1</i> deletion enhances cross-priming of CD8+ T cells by tumor-infiltrating CD11b+ dendritic cellsMelissa Bonner, David Askew, Vrishabhadev Sathish Kumar, et al.
Pageof 1